Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
| Image |  |
|---|---|
| Description | scientific article published on 01 November 2000 |
| Author/s |
author: Mona Landin-Olsson Lennarth Nyström |
| Publication date | 2000 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |